Urinalysis Market to worth $5.7 billion by 2027

Komentar · 554 Tampilan

The global urinalysis market in terms of revenue was estimated to be worth $3.9 billion in 2022 and is poised to reach $5.7 billion by 2027, growing at a CAGR of 8.1% from 2022 to 2027.

According to the new market research report "Urinalysis Market by Product (Dipsticks, Pregnancy Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) Test Type - Global Forecast to 2027"

The globalurinalysis marketin terms of revenue was estimated to be worth $3.9 billion in 2022 and is poised to reach $5.7 billion by 2027, growing at a CAGR of 8.1% from 2022 to 2027.

Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=194978883

Driver: Increasing burden of UTIs, diabetes and liver kidney diseases
There is a widespread application of urinalysis in the diagnosis and management of diseases like kidney and liver diseases. Urinalysis enables clinicians to assess the level of chemical compounds in the urine. These factors will drive the market growth.

Opportunity: Emerging market
the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in emerging countries play an essential role in upgrading laboratory infrastructure.

Restraint: Availability of refurbished urine analyzers
In developing countries, which are price-sensitive, prefer instruments that are cheap and offer similar functionalities. In the absence of well-grounded regulatory frameworks, there may be an influx of low-quality and refurbished products into the economy. These devilow cost analyzers will hamper the market growth.

Market key Players

Prominent players in urinalysis market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics (UK), Thermo Fisher Scientific Inc. (US), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (UK), Alphatech Scientitfic (Peru), Teco Diagnostics (US), Analyticon Technologies AG (Germany), Bioway Biological Technology Co. Ltd. (China), High Technology Inc. (US) and Agappe Diagnostics Ltd. (India)

Report Objectives

  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically analyze the market structure and profile the key players of the market and comprehensively analyze their core competencies
  • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East Africa)
  • To track and analyze competitive developments such as product launches, acquisitions, partnerships, agreements, and collaborations in the 55 during the forecast period

Explore the Full Report with Charts, Table of Contents, and List of Figures:https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the companys specific needs.

Get 10% Free Customization on this Report-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=194978883

Company information

Detailed analysis and profiling of additional market players (up to 20)

About MarketsandMarkets:

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the GIVE Growth principle, we work with several Forbes Global 2000 B2B companies -helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, and facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn, and Facebook.

Contact:

Mr. Aashish Mehra

MarketsandMarkets INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +18886006441

Email:sales@marketsandmarkets.com

Komentar